Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By boosting these receptors, Retatrutide controls cravings, {promotesenergy expenditure, and ultimately contributes to significant reduction in body mass. While stu… Read More